MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

DexCom Inc

Suletud

SektorTervishoid

67.28 -1.39

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

66.29

Max

68.17

Põhinäitajad

By Trading Economics

Sissetulek

17M

152M

Müük

119M

1.1B

P/E

Sektori keskmine

47.409

63.778

Aktsiakasum

0.45

Kasumimarginaal

13.624

Töötajad

10,200

EBITDA

5M

242M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+51.41% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

24. apr 2025

Turustatistika

By TradingEconomics

Turukapital

-7.9B

26B

Eelmine avamishind

68.67

Eelmine sulgemishind

67.28

Uudiste sentiment

By Acuity

15%

85%

27 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

DexCom Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. okt 2024, 09:10 UTC

Tulu

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

26. juuli 2024, 20:16 UTC

Tulu

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26. juuli 2024, 09:13 UTC

Peamised uudised
Kuumad aktsiad

Stocks to Watch: DexCom, Coinbase, 3M, Hermès -- WSJ

26. juuli 2024, 08:56 UTC

Peamised uudised

These Stocks Are Moving the Most Today: DexCom, Deckers, Coursera, Ford, Alphabet, Bristol Myers, 3M, and More -- Barrons.com

27. juuni 2024, 16:01 UTC

Tulu

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

DexCom Inc Prognoos

Hinnasiht

By TipRanks

51.41% tõus

12 kuu keskmine prognoos

Keskmine 103.4 USD  51.41%

Kõrge 120 USD

Madal 82 USD

Põhineb 18 Wall Streeti analüütiku instrumendi DexCom Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

18 ratings

16

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

66.25 / 72.47Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

27 / 386 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.